Fenoldopam Mesylate and Renal Function in Patients Undergoing Liver Transplantation: A Randomized, Controlled Pilot Trial
2004; Lippincott Williams & Wilkins; Linguagem: Inglês
10.1213/01.ane.0000136420.01393.81
ISSN1526-7598
AutoresCarlo Della Rocca, L. Pompei, Maria Gabriella Costa, Cecilia Coccia, Luigia Scudeller, Paola Di Marco, S. Monaco, P Pietropaoli,
Tópico(s)Liver Disease and Transplantation
ResumoIn Brief To test the relative effects on serum creatinine (CRE), blood urea nitrogen (BUN), and urine output of small-dose dopamine and fenoldopam in patients undergoing liver transplantation, we randomized 43 patients to 1 of 2 continuous infusions over 48 h, starting with anesthesia induction: fenoldopam, 0.1 μg · kg−1 · min−1 or dopamine, 2 μg · kg−1 · min−1. We used predetermined hemodynamic and intravascular volume goals (intrathoracic blood volume index 800–1000 mL/m2, extravascular lung water index 1 mL · kg−1 · h−1. At postoperative day 3, the median CRE increase was 0.2 mg/dL (interquartile range [IQR] −0.2–0.5) with fenoldopam and 0.5 mg/dL (IQR 0.3–0.9, P = 0.004) in the dopamine group. The BUN increase was median 2 mg/dL (IQR −2–8) versus 8.5 mg/dL (IQR 5–12, P = 0.01), respectively, with fenoldopam versus dopamine. Urine output was similar; however, significantly fewer fenoldopam patients required furosemide compared with dopamine patients (median 1 [IQR 0–3] versus 3 [IQR 2–4], respectively, P = 0.003). The hemodynamic effects of dopamine and fenoldopam were similar. Compared with dopamine, in the setting of liver transplantation, fenoldopam is associated with better CRE and BUN values. IMPLICATIONS: We evaluated renal function comparing fenoldopam versus dopamine in liver transplantation recipients. In the fenoldopam-treated group, serum creatinine and BUN improved. There were more "interventions" of furosemide to maintain urine output >1 mL · kg−1 · h−1 in the dopamine group.
Referência(s)